Showing 13,981 - 14,000 results of 57,800 for search '(( 2 e decrease ) OR ( 100 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.63s Refine Results
  1. 13981
  2. 13982
  3. 13983
  4. 13984
  5. 13985
  6. 13986

    Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in GRADE: A Randomized Clinical Trial by Jeffrey S. Gonzalez (17468874)

    Published 2024
    “…Research Design and Methods: The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study of adults with T2DM of < 10 years duration, HbA1c of 6.8-8.5%, and taking metformin monotherapy randomly assigned participants to add insulin glargine U-100, sulfonylurea glimepiride, glucagon-like peptide-1 receptor agonist liraglutide, or dipeptidyl peptidase 4 inhibitor sitagliptin. …”
  7. 13987

    Presentation_1_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.PDF by David Grünig (3704716)

    Published 2018
    “…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”
  8. 13988

    Image_2_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

    Published 2018
    “…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”
  9. 13989

    Image_4_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

    Published 2018
    “…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”
  10. 13990

    Image_1_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

    Published 2018
    “…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”
  11. 13991

    Image_3_Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.TIF by David Grünig (3704716)

    Published 2018
    “…Tamoxifen and WIN 55,212-2 decreased cellular ApoB-100 excretion. In conclusion, the established inhibitors of fatty acid metabolism caused the expected effects in HepG2 cells. …”
  12. 13992
  13. 13993

    E4-ORF1 induces PBM-, PI3K-, and Dlg1-dependent cellular transformation. by Kathleen Kong (558240)

    Published 2014
    “…(<b>E</b>) Dlg1 depletion decreases the growth of <i>wt</i>ORF1 cells in soft agar. …”
  14. 13994
  15. 13995

    Als acts downstream of GSK3β and upstream of SCF/Slimb/βTRCP E3 Ub ligase. by Gerlinde Reim (654594)

    Published 2014
    “…(B and C) The positive Wg targets <i>nkd</i> and <i>wf</i> were induced upon GSK3β inhibition (bar 2 in [B and C]) and E1 ligase inhibition (bar 3 in [B and C]) in control cells. …”
  16. 13996
  17. 13997

    TNFα drives increased oxidative stress in aortic valve endothelial cells via eNOS uncoupling. by Emily J. Farrar (721281)

    Published 2015
    “…<b>D</b>, TNFα or H<sub>2</sub>O<sub>2</sub> decrease eNOS and VE-cadherin expression in VEC at 48 hours. …”
  18. 13998

    Tumor vessel activity is inhibited by 6a-P peptide. by Tong-Young Lee (250877)

    Published 2010
    “…Immunohistochemistry result shows that VEGF/KDR complexes are colocalized with vessels (VWF staining) on PBS treated tumor (A; up panel). However, the staining signal is decreased after peptide treatment (A; lower panel). …”
  19. 13999
  20. 14000